Skip to main content

HubXchange

HubXChange logo

CNS Therapeutics Xchange - Boston - 2024

Page Banner 1

Loading
  1. Drug Delivery
    Sponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]
    Sponsor Led Roundtable: Utilizing Innovative Strategies and Collaborations to Address Challenges in Neurodegenerative Trials [Clinical Studies Topic]
    24-Jun-2024
    • Drug Delivery
     
    Jimmy El Hokayem, Vice President, Program Development and Medical Insights - Biorasi
  2. Evening Drinks Reception
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  3. Drug Delivery
    Non-Invasive Drug Delivery for CNS indications
    24-Jun-2024
    • Drug Delivery
    Delivery approaches for CNS indications Targeting to CNS Full CNS exposure Specific targeting within CNS Compound-dependent options Disease-dependent strategies
    Asli Sahin, Director, S&E Neuroscience - AbbVie
  4. Preclinical
    Artificial intelligence and Machine Learning methods to identify, define, rank and analyze Biomarkers in preclinical, translational medicine and clinical studies
    24-Jun-2024
    • Preclinical
    Anil Tarachandani, Vice President and Head of Translational Medicine - Verge Genomics
  5. Clinical Studies
    Approaches to Natural history studies and real world data to inform endpoint selection
    24-Jun-2024
    • Clinical Studies
     
    Aneeta Saxena, Medical Director (Epilepsy and Neurodevelopment) - Biogen
  6. Preclinical
    Poster Presentation: From Screening to Translation: Porsolt's Integrated Approach to Seizure Research
    Poster Presentation: From Screening to Translation: Porsolt's Integrated Approach to Seizure Research
    24-Jun-2024
    • Preclinical
     
    Kendall Walker, Director of Business Development - North America - Porsolt
  7. Clinical Studies
    Poster Presentation: New FDA Guidance on Data Monitoring Committees (DMCs) and Recommended Unblinded Data Reporting Practices for Effective Clinical Trial Oversight
    Poster Presentation: New FDA Guidance on Data Monitoring Committees (DMCs) and Recommended Unblinded Data Reporting Practices for Effective Clinical Trial Oversight
    24-Jun-2024
    • Clinical Studies
     
    Kirby Morgan, Senior Biostatistician - IDDI
  8. Spotlight Presentation: 'A Guide through Preclinical Drug Testing Systems for Neuroinflammation
    Spotlight Presentation: 'A Guide through Preclinical Drug Testing Systems for Neuroinflammation
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
     
    Stefan Ebner-Benke, Head of Study Coordination - Scantox Neuro
  9. Novel Targets
    Poster Presentation: CNS-Targeted Therapies Delivery Strategies and Sampling in Non-Rodent Preclinical Species: Considerations During Early Phase Discovery to IND-Enabling Regulatory Studies [Preclinical Topic]
    Poster Presentation: CNS-Targeted Therapies Delivery Strategies and Sampling in Non-Rodent Preclinical Species: Considerations During Early Phase Discovery to IND-Enabling Regulatory Studies [Preclinical Topic]
    24-Jun-2024
    • Novel Targets
     
    Norbert Makori BVM MSc PhD DABT, Vice President Toxicology, Preclinical - Altasciences
  10. 1-2-1 Meetings / Networking Break
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  11. 1-2-1 Meetings / Networking Break
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  12. Spotlight Presentation: The emergence Light sheet fluorescence microscopy and virtual neuroscience in preclinical drug development
    Spotlight Presentation: The emergence Light sheet fluorescence microscopy and virtual neuroscience in preclinical drug development
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
     
    Jacob Hecksher-Sørensen, Director of imaging and innovation - Gubra
  13. Networking Lunch
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  14. Registration
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  15. Clinical Studies
    Sponsor Led Roundtable: Managing Complexity in CNS Trials for Biotech
    Sponsor Led Roundtable: Managing Complexity in CNS Trials for Biotech
    24-Jun-2024
    • Clinical Studies
     
    Mike Cioffi, Senior Vice President, Clinical Solutions and Strategic Partnerships - WCG Clinical
  16. Preclinical
    Sponsor Led Roundtable: How to select pre-clinical models for assessment of disease modification and symptomatic benefit in Parkinson's disease
    Sponsor Led Roundtable: How to select pre-clinical models for assessment of disease modification and symptomatic benefit in Parkinson's disease
    24-Jun-2024
    • Preclinical
    Tom Johnston, COO - Atuka
  17. Novel Targets
    Sponsor Led Roundtable: Histology and IHC in CNS Drug Discovery: 2D or 3D? [Preclinical Topic]
    Sponsor Led Roundtable: Histology and IHC in CNS Drug Discovery: 2D or 3D? [Preclinical Topic]
    24-Jun-2024
    • Novel Targets
     
    Damian Wheeler, CEO - Translucence Biosystems
  18. Morning Refreshments
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  19. Preclinical
    Implementing novel preclinical organoid and in vivo models to investigate subtype-selectivity and cross-species activity of CNS therapeutics.
    24-Jun-2024
    • Preclinical
     
    Noah Druckenbrod, Assoc. Director Discovery - Decibel Tx
  20. 1-2-1 Meetings / Networking Break
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  21. Drug Delivery
    Technological advances for effective CNS Drug Delivery: ligand conjugation, emerging modalities, and model systems
    24-Jun-2024
    • Drug Delivery
     
    Mangala Soundar, Senior Director, Discovery Neurology - PepGen
  22. 1-2-1 Meetings / Networking Break
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
  23. Clinical Studies
    Implementing precision medicine trial designs to overcome the challenge of small and heterogeneous patient populations in rare diseases
    24-Jun-2024
    • Clinical Studies
     
    Daniel Klamer, Vice President (Business Development & Scientific Strategy) - Anavex Life Sciences
  24. Novel Targets
    Leveraging in vivo phenotypic screens for novel target discovery in neurological disorders
    24-Jun-2024
    • Novel Targets
     
    Shane Hegarty, CSO - Axonis Therapeutics
  25. Opening Address & Keynote Presentation: Translational Applications of Molecular and Functional Imaging In Optimisation of the Drug Discovery Pipeline
    Opening Address & Keynote Presentation: Translational Applications of Molecular and Functional Imaging In Optimisation of the Drug Discovery Pipeline
    24-Jun-2024
    • Clinical Studies
    • Drug Delivery
    • Novel Targets
    • Preclinical
     
    Lisa Wells, Head of CNS Applications - Invicro
Search